B Cell News and Research

RSS

Pittcon to raise autism awareness during 2019 conference

Pittcon, the premier annual conference and exposition on laboratory science being held in Philadelphia, PA March 17-21 2019, is proud to announce its autism awareness efforts during this year’s conference.

From Pittcon 8 Mar 2019

UCSF scientists develop new strategy for targeting key Parkinson's molecule

UC San Francisco researchers have for the first time developed a strategy for targeting a key molecule implicated in Parkinson's disease, opening up a potential new treatment strategy for the currently incurable movement disorder.

8 Mar 2019

Creating increasingly complex brain organoids

Scientists improved the initial steps of a standard protocol and produced organoids displaying regionalized brain structures, including retinal pigmented cells. The announcement was published today in BMC Developmental Biology by the D'Or Institute for Research and Education's team.

8 Mar 2019

Researchers elucidate how embryonic cells and tissues respond to force

Accumulated evidence suggests that physical force plays an important role in various developmental processes of fertilized animal eggs.

8 Mar 2019

Researchers find cause, treatment for CVID lung disease using precision medicine

Researchers have identified that dysfunction of a specific immune cell, called B cells, underlies lung disease that affects patients with the rare immunological disorder known as common variable immunodeficiency.

8 Mar 2019

Researchers move one step closer to finding a cure for spina bifida

Researchers on the path to finding a cure for spina bifida have identified specific elements in stem cell secretions as key to protecting neurons and ultimately reducing the lower-limb paralysis associated with the birth defect.

8 Mar 2019

Getting closer to a scary 'post-antibiotic world'

The products of wastewater treatment have been found to contain trace amounts of antibiotic resistant DNA. These products are often reintroduced to the environment and water supply, potentially resulting in the spread of antibiotic resistance.

8 Mar 2019

Scientists shed light on key mechanism linked to development of healthy cells

Scientists have shed light on how healthy cells develop by identifying the role of key molecules involved.

8 Mar 2019

Research team identifies potential target protein aggregates for treating Alzheimer's disease

The aggregation of alpha-synuclein proteins in Parkinson's disease and tau proteins in Alzheimer's disease is intimately linked to the progression of these neurodegenerative diseases. These aggregates propagate from one neuronal cell to another, attaching themselves to the cells.

8 Mar 2019

DNA sequencing method could aid development of anticancer drugs

DNA is small. Really, really, small. So, when researchers want to study the structure of a single-stranded DNA, they can't just pull out their microscopes: they have to get creative.

8 Mar 2019

Researchers find potential new target for chronic pain treatment

A research group at Hiroshima University observed a potential new target for chronic pain treatment. Further research using this receptor could lead to new, more effective drugs to use in pain-relieving treatment for chronic pain.

7 Mar 2019

HIV patients diagnosed with tuberculosis more likely to die within 10 years, study finds

Among people with HIV in Latin America, those diagnosed with tuberculosis at an initial clinic visit were about twice as likely to die within 10 years as people not initially diagnosed with TB, according to findings from a large observational study.

7 Mar 2019

Mechanism through which bacteria attack the immune system discovered

A research team led by Prof. Dr. Winfried Römer and Dr. Elias Hobeika from the University of Freiburg and the University Medical Center in Ulm has discovered a mechanism with which bacteria activate white blood cells and attack an organism's immune system. The scientists recently published the results in the journal Science Signaling.

7 Mar 2019

ACROBiosystems collaborates with ProMab Biotechnologies to develop immunotherapy products

ACROBiosystems, a leading manufacturer of recombinant proteins, announced that they have signed a collaboration agreement with ProMab Biotechnologies, a leading manufacturer of monoclonal antibodies and CAR-T cells.

From ACROBiosystems 7 Mar 2019

AvantGen and ACROBiosystems sign vendor agreement

AvantGen Inc., a world-leading CRO for human and rabbit antibody discovery and optimization, and ACROBiosystems Inc., a global biotech company specializing in recombinant protein technology jointly announced the signing of a preferred vendor agreement between the parties.

From ACROBiosystems 7 Mar 2019

CAR-T cell therapy could be on the horizon for patients with lupus

Researchers have developed a novel CAR-T cell therapy that can reduce B cell numbers known to cause the inflammatory responses in lupus.

7 Mar 2019

Common fungus found on skin may cause inflammatory bowel disease

Therapies that target certain commensal fungi could provide a new way of treating inflammatory bowel disease (IBD), according to researchers.

6 Mar 2019

Research offers new hope for seasonal allergy sufferers

One in three people is plagued by an allergy, triggered by foodstuffs, fungi, house dust mites or on a seasonal basis due to pollen. The latter group is the largest: around 800 million people worldwide suffer from some form of allergy to pollen, with the usual symptoms such as a runny nose, cough and severe breathing problems.

6 Mar 2019

Fasting-mimicking diet changes gut microbiota to reduce IBD pathology in mice

Dietary modifications are frequently used to treat inflammatory bowel diseases.

6 Mar 2019

Study to generate evidence on impact of pharmaceutical industry-led medicines access program

Study of Novartis Access program in Kenya demonstrates it is possible to evaluate major pharmaceutical companies' access programs using robust, 'gold standard' methods.

6 Mar 2019